Investor Relations
A Vertically Integrated Botanical Pharmaceutical Platform
VITI GROUP pairs proprietary green-chemistry extraction with a blockchain-governed contract farming network and a growing portfolio of pharmaceutical-grade botanical products.
Market Opportunity
A Growing Market for Standardized, Traceable Botanical Ingredients
Demand for pharmaceutical-grade botanical extracts is rising as food, feed, and pharmaceutical manufacturers seek standardized, traceable natural ingredients over unstandardized commodity crops. Regulatory tightening around API quality, growing nootropic and functional-food demand, and buyer preference for verifiable supply chains all favor manufacturers who combine agricultural sourcing with in-house extraction science.
- Rising nootropic and cognitive-health supplement demand
- Functional food and beverage manufacturers seeking standardized natural actives
- Buyer preference for traceable, ethically sourced agricultural inputs
- Increasing scrutiny of botanical API quality and consistency across the supply chain
Business Model
Two Reinforcing Revenue Lines
VITI's model spans from cultivation to finished product, capturing margin at each stage while sharing upside with the growers who supply it.
Standardized Ingredient Sales
B2B sale of pharmaceutical-grade botanical extracts and functional ingredients — standardized kratom extract, turmeric extract, alkaloid-infused edibles and RTD beverages, sensors, and next-generation proteins — to food, feed, and pharmaceutical manufacturers.
Contract Pharming Network
A blockchain-governed contract farming program: pharmers are paid for raw material and receive a share of revenue from the finished consumer products derived from their crops, aligning supply growth with product success.
Product Portfolio
A Growing Pipeline of Pharmaceutical-Grade Botanical Products
The current catalog, adjacent platform technologies, and near-term development goals are all built on the same in-house extraction science.
Our Products
Standardized Kratom Extract
High-purity extract from Mitragyna speciosa leaves, standardized for consistent alkaloid content with Mitragynine as the primary marker. Produced under strict quality control at our EECi API Facility.
Mitragyna Alkaloid Infused Edible
Crafted with carefully measured alkaloids, this edible delivers a standardized and consistent experience in a convenient format. Designed for smooth taste, precise infusion, and reliable quality across every batch.
Alkaloid Infused Ready-to-Drink
A smooth, convenient RTD beverage infused with precision-measured alkaloids for consistent quality and standardized potency. Balanced formulation for on-the-go use with clean ingredient sourcing.
Turmeric Standardized Extract
High-purity extract from Curcuma longa rhizomes, standardized for curcuminoid content with curcumin as the primary marker. FCC grade — suitable for dietary supplements, functional foods, and cosmeceuticals.
Sensors, Devices & Next Generation Proteins
Sensors & Devices
Advanced nanotechnology sensor films and precision devices for rapid detection, research monitoring, and industrial-scale quality measurement.
Next Generation Proteins
Bioavailable protein formulations designed to support beauty, mobility, and wellness. Purpose-built for dietary supplements and functional foods.
Functional Ingredients
Bioactive ingredients for immunity support, anti-aging, and metabolic regulation — tailored for food, beverage, and supplement manufacturers.
Shared Vision, Shared Progress
Novel Pharmaceutical Products
Pioneering a new era in pharmaceutical innovation by developing novel and impactful botanical APIs. Leveraging cutting-edge extraction research to bring standardized, traceable therapies to market.
New Nootropic Supplements
Leading the development of innovative and effective nootropic supplements. Unlocking the full potential of the human mind through science-backed natural formulations derived from botanicals.
Why VITI
Durable Advantages Across the Value Chain
Proprietary Extraction Technology
In-house ultrasonic "disruptive frequency" and micellar extraction methods, developed from first principles and validated for pharmaceutical-grade purity — not licensed or outsourced.
Blockchain-Governed Supply Network
Every pharmer is bound by an on-chain smart contract; profit-sharing aligns grower incentives with the commercial success of finished products, creating a supply network that takes years to replicate.
Vertical Integration
From GAP-certified cultivation, through EECi API-grade extraction, to finished consumer formats — margin capture and supply certainty at every stage.
Compliance-Oriented Manufacturing
Processes and quality systems built toward ICH Q7 and PIC/S PE 007 standards, positioning export-grade output for regulated international pharmaceutical markets.
Thailand EECi Location
Operating inside Thailand's Eastern Economic Corridor of Innovation — government-backed research infrastructure and proximity to the botanical raw material this industry depends on.
Growth Priorities
Where We're Focused Next
Forward-looking priorities, not commitments or guarantees of future results.
Expand API Facility Capacity
Scale extraction throughput at the EECi facility to support a growing customer base.
Grow the Pharmer Network
Onboard additional GAP-certified growers under the contract pharming program to secure raw material supply.
File a Drug Master File (DMF) for API Products
Once this raise is complete, file a Drug Master File (DMF) with the US FDA and other regulatory authorities for VITI's standardized botanical APIs — building the quality documentation and ICH Q7 / PIC/S alignment needed to support customers in regulated pharmaceutical markets.
Launch Additional Nootropic & Functional Formats
Extend the product portfolio into new nootropic supplement and functional-ingredient formats.
Investment Risk Disclosure
Investment in an early-stage botanical extraction and agricultural technology company carries significant risk, including the risk of total loss. Statements about market opportunity, growth priorities, and product plans are forward-looking and illustrative, not guarantees of future performance or regulatory outcomes. This page does not constitute a securities offering or investment advice. Consult qualified financial and legal advisors before making any investment decision.
Investor Enquiry
Get in Touch With Our Team
For investment enquiries, partnership discussions, or to request additional information, reach out using the form below or email us directly.
API Facility
Eastern Economic Corridor of Innovation (EECi)Wang Chan District, Rayong Province, 21210, Thailand